Feature
COVID-19: Roche Collaborates with Boston-Based Biopharma To Develop First Novel Oral Antiviral
2020-10-23
First to the Finish Line! Remdesivir Becomes the First and Only FDA Approved Drug to Treat COVID-19
2020-10-23
Taiwan’s TTY Biopharm Company Signs COVID-19 Vaccine Deal with BioNTech for 30 Million Doses
2020-10-20
Structural Study of SARS-CoV-2 Spike Protein Aids in Better Understanding of COVID-19 Infection
2020-10-18
Regeneron’s FDA Success with Ebola Treating Antibody Cocktail, Inmazeb, Bodes Well for its COVID-19 Candidate
2020-10-16
HoldingTOP Delivers a Mobilized Long-Term Care Service, a First in Taiwan
2020-10-13Partner
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115